Mitigating Increased Cardiovascular Risk in Patients with Obstructive Sleep Apnea Using GLP-1 Receptor Agonists and SGLT2 Inhibitors: Hype or Hope?

Obstructive sleep apnea (OSA) is a prevalent condition associated with increased cardiovascular risk, particularly in individuals with comorbid obesity and type 2 diabetes (T2D). Despite the widespread use of continuous positive airway pressure (CPAP) for OSA management, adherence remains suboptimal...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Paschalis Karakasis, Marios Sagris, Dimitrios Patoulias, Theocharis Koufakis, Panagiotis Theofilis, Aleksandra Klisic, Nikolaos Fragakis, Mohamed El Tanani, Manfredi Rizzo
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2024-11-01
Reeks:	Biomedicines
Onderwerpen:	obstructive sleep apnea glucagon-like peptide-1 receptor agonists sodium-glucose cotransporter-2 inhibitors cardiovascular risk obesity type 2 diabetes
Online toegang:	https://www.mdpi.com/2227-9059/12/11/2503
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!